Pairing Verana Health’s data with robust patient journey insight in Komodo’s Healthcare Map will arm life sciences researchers with complete view of patient encounters with the healthcare system.
Suono Bio, founded by two MIT professors and an alumnus, is using a proven technology to boost the treatment of gastrointestinal tract disorders.
Velano’s hardware will slot in among the other ubiquitous products in BD’s hefty blood collection portfolio, such as the ever-present, multicolored Vacutainer tubes as well as vascular access needles and other IV equipment.
CloudCath recently announced a partnership with American Renal Associates, an outpatient dialysis provider, with the aim of conducting a pre-market clinical study of its product in peritoneal dialysis patients.
“My career path has looked different from a lot of people, because I’m always looking to follow my passions, and I always have this curious mindset to keep learning.”
Woebot’s technology centers around the eponymous “digital therapist,” which uses conversational AI software to form therapeutic bonds with users as they discuss mental health issues.
The grant will provide up to $2.1 million to support the development of gel embolic material for transcatheter embolization.
Suono Bio will utilize the funds to advance its lead programs in inflammatory bowel disease as well as expansion of its pipeline.
The devices can be injected into patients during intra-arterial chemotherapy, to drain affected organs and prevent toxic agents from entering their bloodstream.
“This funding provides us with the resources to advance key clinical programs and partnerships assessing remote monitoring benefits for chronic kidney disease and dialysis patients.”